# A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

> **NCT05214677** · PHASE1 · COMPLETED · sponsor: **Daewon Pharmaceutical Co., Ltd.** · enrollment: 38 (actual)

## Conditions studied

- Osteoarthritis
- Rheumatoid Arthritis
- Back Pain
- Acute Upper Respiratory Tract Infection

## Interventions

- **DRUG:** DW1809
- **DRUG:** DW1809-1

## Key facts

- **NCT ID:** NCT05214677
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-15
- **Primary completion:** 2020-09-07
- **Final completion:** 2020-09-07
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05214677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05214677, "A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05214677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*